How much is Wegovy in Australia?
Wegovy (semaglutide) is not on the PBS, so in Australia you pay the full private price, which differs by strength. Australian advertising rules limit who may publish prescription-medicine prices, so we don't print them. A pharmacist can tell you the price for the dose on your script.
- Every GLP‑1 medicine is prescription-only in Australia, so a prescriber has to assess you first.1
- We don't publish medicine prices, and we don't name, rank or link to sellers or telehealth services.
- Products sold online as “GLP‑1” drops, patches or peptides are not the same thing: see Do GLP‑1 patches or drops work?
- Nothing here promises any result, and nothing here is for sale.
Why is there no PBS price for Wegovy?
Wegovy is not PBS-listed for any use, so there is no capped PBS charge and you pay the full amount.2,3
The PBAC recommended Wegovy in November 2025 for some adults with obesity and a past cardiovascular event, but as of the PBS status page's last update on 23 July 2026 the listing had not happened.2 Even if it happens, it would cover only that group.4 The details are in Is Wegovy on the PBS?
Why don't we publish a price?
Under TGA rules, price information about a prescription medicine generally counts as advertising, which only community pharmacies and a few other groups may publish.5
Even they may publish only price lists that meet set conditions, such as covering 25 medicines or more.5 Advertising any GLP‑1 medicine to the public is illegal, the TGA says.6 So we explain how the cost works and leave the figures to the pharmacist.
What changes the amount you pay?
The dose you're on: each Wegovy FlexTouch pen holds four weekly doses, and doses rise over 16 weeks from 0.25 mg to 2.4 mg.7
For adults who started with a BMI of 30 or more, the Australian label also allows 7.2 mg a week, given as three 2.4 mg injections one after another.7 That uses three times as much medicine as the 2.4 mg dose, so ask the pharmacist how it changes the cost. The July 2024 Australian Obesity Management Algorithm, which estimated monthly costs from pharmacy websites, shows the 1.7 mg and 2.4 mg strengths costing more than the lower ones.8
If you have extras cover, ask your insurer whether it pays toward non-PBS medicines; most set a co-payment and limits.3 The doctor's visit is separate, and Medicare pays the MBS fee for a GP visit outside hospital.3
- Stomach effects are very common. Over 68 weeks on the Australian Wegovy label, about 44 in 100 people had nausea, against 16 in 100 on a dummy injection.7
- Gallstones were reported in 1.6 in 100 people on Wegovy and 1.1 in 100 on a dummy injection; confirmed acute pancreatitis in 0.2 in 100 (2 in 1,000), against under 1 in 1,000.7
- Pregnancy. Semaglutide is pregnancy category D in Australia.8
Read the full picture
Related questions
Sources
- TGA. Counterfeit weight loss products claiming to contain GLP-1. Safety advisory, 2 Mar 2026. tga.gov.au
- PBS. Medicine status: semaglutide (Wegovy), established cardiovascular disease with obesity, document 1460. Page last updated 23 Jul 2026. pbs.gov.au
- privatehealth.gov.au (Commonwealth Ombudsman). What is covered: Medicare, the PBS and private health insurance. privatehealth.gov.au
- newsGP (RACGP). Wegovy recommended for PBS listing, 19 Dec 2025. racgp.org.au
- TGA. Applying the Advertising Code rules: price information. Updated 21 Jul 2026. tga.gov.au
- TGA. Advertising Ozempic and GLP-1 receptor agonists is prohibited. Updated 11 Mar 2025. tga.gov.au
- Novo Nordisk. Wegovy (semaglutide) Australian Product Information, date of revision 22 Jun 2026, sections 2, 4.1, 4.2, 4.8 and 6.4. Australian label. medsinfo.com.au (PDF)
- Australian Diabetes Society, ANZOS, ANZMOSS and RACGP. Australian Obesity Management Algorithm, July 2024. diabetessociety.com.au (PDF)
Last checked 12 Oct 2026 · Next review due 12 Apr 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on 12 Oct 2026. We don't publish medicine prices, and we don't name, rank or link to sellers or telehealth services. It's general information, not medical advice, and nothing here is an offer to supply any medicine. Talk to a GP, pharmacist or other qualified prescriber before starting, stopping or changing any medicine. How we write